NASDAQ$HSIC
Henry Schein Inc · Q3 2021 earnings
Q3 2021 earnings · · Investor relations
Briefing
Henry Schein reported record financial results for Q3 2021, driven by strong execution and patient traffic.
Henry Schein reported record third-quarter financial results with net sales of $3.2 billion, up 11.9% year-over-year. GAAP diluted EPS was $1.15, compared to $0.99 in the prior year, and non-GAAP diluted EPS was $1.10, compared to $1.03 in the prior year. The company increased its 2021 non-GAAP diluted EPS guidance to a range of $4.27 to $4.35 and introduced preliminary guidance for 2022.
- Total net sales reached $3.2 billion, reflecting an 11.9% increase compared to the previous year.
- GAAP diluted EPS from continuing operations was reported at $1.15, an increase from $0.99 in the prior year.
- Non-GAAP diluted EPS from continuing operations was $1.10, up from $1.03 in the previous year.
- The company increased its 2021 guidance for non-GAAP diluted EPS from continuing operations to between $4.27 and $4.35.
Headline financials
Revenue & EPS history
Henry Schein · Revenue · Quarterly
$3.18B
Revenue by segment
Henry Schein · $3B total across 2 segments · Q3 2021
- Global Dental$1.8B+9.1%60.0%
- Global Medical$1.2B+16.8%40.0%
Forward guidance
Henry Schein provided financial guidance for 2021 and preliminary guidance for 2022 non-GAAP diluted EPS from continuing operations, with growth expected in the mid to high single digits for 2022.
Tailwinds
- 2021 non-GAAP diluted EPS from continuing operations is expected to be $4.27 to $4.35.
- The EPS guidance reflects growth of 44% to 46% compared with 2020.
- The 2022 non-GAAP diluted EPS from continuing operations is expected to grow in the mid to high single digits over 2021.
- The guidance includes current continuing operations.
- The guidance includes completed or previously announced acquisitions.
Headwinds
- The company is not providing guidance for 2021 GAAP diluted EPS from continuing operations.
- The company is not providing guidance for 2022 GAAP diluted EPS from continuing operations.
- Guidance does not include the impact of future share repurchases.
- Guidance does not include potential future acquisitions, if any.
- Guidance does not include restructuring expenses.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2021
-0.4%
Avg return
Earnings day
-0.5%
Avg return
5 days after
-0.6%
Avg return
30 days after
45%
31 / 69 earnings
Positive
+11.1%
Q4 2021
Best reaction
-8.5%
Q3 2017
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +3.3% | -1.6% | +4.6% | |
| Q4 2025 | +5.8% | +2.3% | -8.5% | |
| Q3 2025 | +10.9% | +11.2% | +13.5% | |
| Q1 2025 | +2.0% | +5.1% | +7.8% | |
| Q4 2024 | -2.3% | -7.0% | -10.6% | |
| Q3 2024 | -3.2% | -6.0% | +0.2% | |
| Q2 2024 | -5.4% | -0.9% | +0.4% | |
| Q1 2024 | +6.2% | +7.0% | +0.1% | |
| Q4 2023 | -5.1% | -4.6% | -6.3% | |
| Q3 2023 | +7.5% | +7.3% | +15.5% | |
| Q2 2023 | -2.8% | -1.8% | -5.1% | |
| Q1 2023 | -4.5% | -4.2% | -6.1% | |
| Q4 2022 | -6.2% | -7.5% | -12.8% | |
| Q3 2022 | +1.8% | +6.2% | +21.2% | |
| Q2 2022 | -4.9% | -3.8% | -7.3% | |
| Q1 2022 | +7.4% | +6.6% | +5.6% | |
| Q4 2021 | +11.1% | +10.1% | +14.5% | |
| Q3 2021 | +3.0% | +4.5% | -6.7% | |
| Q2 2021 | -4.8% | -5.2% | -2.3% | |
| Q1 2021 | +6.6% | +8.9% | +5.3% | |
| Q4 2020 | -8.5% | -6.5% | -5.3% | |
| Q3 2020 | -5.0% | -3.0% | +4.6% | |
| Q2 2020 | -5.3% | -4.4% | -6.9% | |
| Q1 2020 | +0.4% | +2.9% | +20.6% | |
| Q4 2019 | -8.4% | -14.4% | -38.9% | |
| Q3 2019 | +4.4% | +4.8% | +5.2% | |
| Q2 2019 | -3.2% | -2.3% | -4.2% | |
| Q1 2019 | +8.6% | +8.9% | +8.6% | |
| Q4 2018 | -5.0% | -5.2% | -5.2% | |
| Q3 2018 | +3.1% | +0.8% | +3.3% | |
| Q2 2018 | -0.5% | -3.6% | +0.5% | |
| Q1 2018 | -6.1% | -4.4% | -6.7% | |
| Q4 2017 | -1.2% | -2.1% | -5.2% | |
| Q3 2017 | -8.5% | -13.6% | -13.0% | |
| Q2 2017 | -7.7% | -7.2% | -4.9% | |
| Q1 2017 | +0.6% | +0.3% | +5.2% | |
| Q4 2016 | +2.7% | +3.2% | +2.0% | |
| Q3 2016 | +4.6% | +6.2% | +1.7% | |
| Q2 2016 | -7.1% | -8.4% | -8.6% | |
| Q1 2016 | -2.5% | — | — | |
| Q4 2015 | +7.0% | — | — | |
| Q3 2015 | +1.1% | — | — | |
| Q2 2015 | -1.9% | — | — | |
| Q1 2015 | -0.4% | — | — | |
| Q4 2014 | +0.9% | — | — | |
| Q3 2014 | +5.4% | — | — | |
| Q2 2014 | -1.8% | — | — | |
| Q1 2014 | -1.7% | — | — | |
| Q4 2013 | +0.1% | — | — | |
| Q3 2013 | -2.6% | — | — | |
| Q2 2013 | -0.3% | — | — | |
| Q1 2013 | +2.1% | — | — | |
| Q4 2012 | -2.2% | — | — | |
| Q3 2012 | -0.6% | — | — | |
| Q2 2012 | +1.8% | — | — | |
| Q1 2012 | +2.4% | — | — | |
| Q4 2011 | +3.4% | — | — | |
| Q3 2011 | -6.4% | — | — | |
| Q2 2011 | -2.3% | — | — | |
| Q1 2010 | -2.0% | — | — | |
| Q1 2011 | +0.5% | — | — | |
| Q4 2010 | -3.9% | — | — | |
| Q1 2009 | -3.9% | — | — | |
| Q4 2008 | -3.9% | — | — | |
| Q3 2009 | -4.1% | — | — | |
| Q3 2010 | -4.1% | — | — | |
| Q2 2010 | +2.1% | — | — | |
| Q4 2009 | +2.1% | — | — | |
| Q2 2009 | +2.1% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro